Welcome
Norgenix Pharmaceuticals is an innovative pharmaceutical company that commercializes and markets novel OTC and prescription products.

Norgenix executes product launches and accelerates market share through acquisitions and strategic alliances. Norgenix provides partners with the following key elements for success:

• Capitalization/acquisition
• Contract Manufacturing
• Packaging
• Marketing
• Wholesale Distribution
• Sales

A wholly owned subsidiary of the J M Smith Corporation, Norgenix Pharmaceuticals is dedicated to building in-licensing opportunities and creating strategic alliances with companies interested in maximizing the value of products that fulfill unmet medical needs in the U.S. marketplace.